Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients

Chest

Volumn 121, Issue 4, 2002, Pages 1070-1078

  Weisberg, Jeffrey ^a   Wanger, Jack ^b   Olson, Jeffery ^c   Streit, Barry ^d   Fogarty, Charles ^e   Martin, Thomas ^f   Casaburi, Richard ^g  

^a Nova Southeastern University   (United States)

^b Bristol Myers Squibb ^*  (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d Tamarac   (United States)

^e Harbor UCLA Research and Education Institute ^*  (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

COPD; Malnutrition; Megestrol acetate; Weight loss

Indexed keywords

FAT; MEGESTROL ACETATE; PLACEBO;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; APPETITE; ARTERIAL GAS; ARTICLE; BODY COMPOSITION; BODY IMAGE; BREATHING DISORDER; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE TOLERANCE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LUNG PRESSURE; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MULTICENTER STUDY; MUSCLE STRENGTH; PNEUMONIA; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; WALKING; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0036206076     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.4.1070     Document Type: Article

References (48)

1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
2. Nutritional assessment and support in chronic obstructive pulmonary disease
3. Nutrition and metabolism in COPD
4. Nutrition in chronic obstructive pulmonary disease
5. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation
6. Diaphragm and body weight in emphysema
7. Body weight in chronic obstructive pulmonary disease: The National Institutes of Health intermittent positive pressure breathing trial
8. Nutritional support in advanced lung disease: A pulmonary cachexia syndrome
9. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease
10. Management of anorexic patients in radiotherapy: A prospective randomized comparison of megestrol acetate and prednisolone
11. Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy
12. Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia
13. Progesterone for outpatient treatment of Pickwickian syndrome
14. Alveolar hypoventilation treated with medroxyprogesterone
15. Medroxyprogesterone acetate and COPD: Effect on breathing and oxygenation in sleeping and awake patients
16. Effect of chlormadinone acetate on ventilatory control in patients with chronic obstructive pulmonary disease
17. Effects of chlormadinone acetate, acetazolamide and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease
18. Effect of chlormadinone acetate on sleep arterial oxygen desaturation in patients with chronic obstructive pulmonary disease
19. Standardization of spirometry, 1994 update
20. Reference spirometric values using techniques and equipment that meet ATS recommendations
21. Maximum respiratory pressures
22. Human body composition: In vivo methods
23. Timed walking tests of exercise capacity in chronic cardiopulmonary illness
24. How should we measure function in patients with chronic heart and lung disease?
25. A measure of quality of life for clinical trials in chronic lung disease
26. The measurement of dyspnea: Contents, interobserver agreement, and physiologic correlates of two new clinical indexes
27. Megestrol acetate in patients with AIDS and cachexia
28. Effects of megestrol acetate (MA) in patients with weight loss associated with chronic obstructive pulmonary disease (COPD): A pilot study
29. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease
30. Skeletal muscle dysfunction in chronic obstructive lung disease
31. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: A placebo-controlled randomized trial
32. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease: A prospective, randomized, controlled study
33. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients
34. Body composition changes in patients who gain weight while receiving megestrol acetate
35. Pharmacologic modulators of respiratory control
36. The pharmacology of respiratory depressants and stimulants
37. Central nervous mechanisms of progesterone action: Application to the respiratory system
38. Induction of adrenal suppression by megestrol acetate in patients with AIDS
39. Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate
40. Clinical adrenal insufficiency in patients receiving megestrol acetate
41. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia
42. Replacement doses of testosterone increase fat-free mass and muscle size in hypogonadal men
43. Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects
44. Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia
45. Interpreting small differences in functional status: The six minute walk test in chronic lung disease patients